Related references
Note: Only part of the references are listed.DNA mismatch repair-dependent activation of c-Abl/p73α/GADD45α-mediated apoptosis
Long Shan Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Distinct effects of the recurrent Mlh1G67R mutation on MMR functions, cancer, and meiosis
Elena Avdievich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Mismatch repair expression in testicular cancer predicts recurrence and survival
Alfredo Velasco et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Mismatch repair status and the response of human cells to cisplatin
Elisabetta Pani et al.
CELL CYCLE (2007)
Modulation of MutS ATP-dependent functional activities by DNA containing a cisplatin compound lesion (base damage and mismatch)
Yuliya Sedletska et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Bcl2 impedes DNA mismatch repair by directly regulating the hMSH2-hMSH6 heterodimeric complex
Yongzhong Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients
Mario Scartozzi et al.
LUNG CANCER (2006)
The molecular mechanism of DNA damage recognition by MutS homologs and its consequences for cell death response
Freddie R. Salsbury et al.
NUCLEIC ACIDS RESEARCH (2006)
Bcl-2 expression suppresses mismatch repair activity through inhibition of E2F transcriptional activity
CK Youn et al.
NATURE CELL BIOLOGY (2005)
Expression of Bcl-XL in ovarian carcinoma is associated with chemoresistance and recurrent disease
J Williams et al.
GYNECOLOGIC ONCOLOGY (2005)
MSH2 missense mutations alter cisplatin cytotoxicity and promote cisplatin-induced genome instability
JE Clodfelter et al.
NUCLEIC ACIDS RESEARCH (2005)
Apoptotic signaling in response to a single type of DNA lesion, O6-methylguanine
MJ Hickman et al.
MOLECULAR CELL (2004)
An Msh2 point mutation uncouples DNA mismatch repair and apoptosis
DP Lin et al.
CANCER RESEARCH (2004)
Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility
GZ Yang et al.
CANCER CELL (2004)
Mismatch repair and DNA damage signalling
L Stojic et al.
DNA REPAIR (2004)
Mutations in the nucleotide-binding domain of MutS homologs uncouple cell death from cell survival
K Drotschmann et al.
DNA REPAIR (2004)
Mismatch repair-dependent G2 checkpoint induced by low doses Of SN1 type methylating agents requires the ATR kinase
L Stojic et al.
GENES & DEVELOPMENT (2004)
Dependence of the cytotoxicity of DNA-damaging agents on the mismatch repair status of human cells
E Papouli et al.
CANCER RESEARCH (2004)
Microtubule-targeted anticancer agents and apoptosis
KN Bhalla
ONCOGENE (2003)
Role of DNA mismatch repair defects in the pathogenesis of human cancer
P Peltomäki
JOURNAL OF CLINICAL ONCOLOGY (2003)
A unified model for apical caspase activation
KM Boatright et al.
MOLECULAR CELL (2003)
The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G(2) checkpoint and to resistance to chemotherapeutic DNA-methylating agents
Y Hirose et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines
UA Sartorius et al.
INTERNATIONAL JOURNAL OF CANCER (2002)